Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Special Drug Use-Results Survey of Parsabiv in Hemodialysis-Related Secondary Hyperparathyroidism
jRCT1080224015Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of etelcalcetide in secondary hyperparathyroidism (SHPT), sponsored by Ono Pharmaceutical. Started Jul 2018; status: completed.
02
Drugs
etelcalcetide
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on jRCT1080224015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224015.